(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INHIXA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

INHIXA

ST13

US500000079331604

Class

5

Filing

79331604

Registration

6938289

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

04/29/2024

Trademark type

Combined

Nice classes

5

Filing date

11/30/2021

Registration date

01/03/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/03/2023

Last transaction

04/29/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

CN

Examiner

MURRAY, DAVID T

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The trademark consists of the stylized word "Inhixa".

Holders and representatives

Holders

SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.

Representatives

Shenzhen Talent Trademark Service

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Dietetic foods adapted for medical use; injectable pharmaceuticals for treatment of anaphylactic reactions; pharmaceutical preparationsanticoagulants; medicines for the treatment of cardiovascular and cerebrovascular diseases; biological preparations for the treatment of cancer; pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; chemical preparations for pharmaceutical or medical purposesfor cardiovascular; antibiotic tablets; pharmaceutical products for the treatment of cancer

Publications

History of USPTO decisions and trademark events.

15 publications found

GPNX

NOTIFICATION PROCESSED BY IB

03/28/2023

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

03/01/2023

XXCR

GENERIC MADRID TRANSACTION CREATED

03/01/2023

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

02/02/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/03/2023

PUBO

PUBLISHED FOR OPPOSITION

10/18/2022

NPUB

NOTICE OF PUBLICATION

09/28/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/09/2022

DOCK

ASSIGNED TO EXAMINER

09/09/2022

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

05/11/2022

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

05/02/2022

MAFR

APPLICATION FILING RECEIPT MAILED

02/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/02/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

02/01/2022

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

01/20/2022

Continuous trademark protection

Get notified about every new filing that threatens INHIXA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.